[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]

[[ timeLabel ]] WATCH LIVE:

Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial

Faster, Cleaner, Better.

Tcr2 Therapeutics Inc (TCRR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Cash Flow for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2017	12-2016	12-2006	12-2005
Cash Flows From Operating Activities
Net Income	-13,070	-9,915	N/A	N/A
Depreciation Amortization	298	220	N/A	N/A
Accounts payable and accrued liabilities	-101	76	N/A	N/A
Other Working Capital	349	222	N/A	N/A
Other Operating Activity	509	17	0	0
Operating Cash Flow	$-12,015	$-9,380	$N/A	$N/A

Cash Flows From Investing Activities
PPE Investments	-388	-869	N/A	N/A
Purchase Of Investment	-6,480	-8,350	N/A	N/A
Sale Of Investment	14,830	N/A	N/A	N/A
Other Investing Activity	-290	0	0	0
Investing Cash Flow	$7,672	$-9,219	$N/A	$N/A

Cash Flows From Financing Activities
Common Stock Issued	44	N/A	N/A	N/A
Other Financing Activity	16,119	22,486	0	0
Financing Cash Flow	$16,163	$22,486	$N/A	$N/A

Beginning Cash Position	7,991	4,105	N/A	N/A
End Cash Position	19,811	7,992	N/A	N/A
Net Cash Flow	$11,820	$3,887	$N/A	$N/A

Free Cash Flow
Operating Cash Flow	-12,015	-9,380	N/A	N/A
Capital Expenditure	-388	-869	N/A	N/A
Free Cash Flow	-12,403	-10,249	0	0